GlassScriptPhysician profile
Jonathan Obinna Nwanagu
NPI 1023087756
$2,135.77
in general payments reported to CMS, 2019-2025
23 companies · $489 in 2025
The $489 reported for 2025 was more than what 80% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $110 · 2020: $527 · 2021: $319 · 2022: $205 · 2023: $371 · 2024: $115 · 2025: $489.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $975.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $974.94 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Daiichi Sankyo INC. | $505.76 | 2019-2023 | Injectafer |
| Abbvie INC. | $277.31 | 2019-2022 | |
| Mayne Pharma Commercial LLC | $248.53 | 2025 | |
| Hologic Sales and Service, LLC | $179.53 | 2019-2022 | |
| Therapeuticsmd, INC. | $141.83 | 2019-2022 | |
| Exeltis, USA INC. | $137.10 | 2020-2025 | Slynd |
| Evofem Biosciences, INC. | $121.97 | 2021-2022 | |
| Hydrofera LLC | $81.03 | 2025 | Hydrofera Blue |
| Millicent US INC | $47.43 | 2025 | Intrarosa, Femring, Femlyv |
| Myovant Sciences INC. | $44.80 | 2021 | |
| Organon LLC | $42.71 | 2024-2025 | Nexplanon |
| Avion Pharmaceuticals | $39.78 | 2020-2021 | |
| Pfizer INC. | $39.60 | 2024 | |
| Shield Therapeutics INC | $37.08 | 2024-2025 | |
| Lundbeck LLC | $31.96 | 2023 | Vyepti |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Convatec INC. | $27.04 | 2024 | |
| Minerva Surgical, INC | $24.82 | 2025 | |
| Aspira Women'S Health INC | $21.78 | 2022 | |
| Exact Sciences Corporation | $20.27 | 2025 | Cologuard Collection Kit |
| Mylan Pharmaceuticals INC. | $19.29 | 2022 | |
| Gynesonics, INC. | $18.85 | 2023 | Sonata Sonography-Guided Transcervical Fibroid Ablation System |
| Sumitomo Pharma America, INC. | $16.32 | 2025 | Myfembree |
| Merck Sharp & Dohme LLC | $10.98 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jonathan Nwanagu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.